David Saito, MD
Otolaryngology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Saito’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A95926 · Current
Licensed to practise in California · since 2006 · expires 2028-01-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$102,056
Medicare paid this office $102,056 for 400 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 137 | $19,526 | $112 |
| Diagnostic exam of voice box using a flexible endoscope | 103 | $15,011 | $128 |
| Short return visit (20+ min) | 141 | $13,619 | $78 |
| New patient visit (45+ min) | 95 | $13,249 | $139 |
| New patient visit (30+ min) | 81 | $8,052 | $99 |
See all 9 services
| Return visit (30+ min) | 137 | $19,526 | $112 |
| Diagnostic exam of voice box using a flexible endoscope | 103 | $15,011 | $128 |
| Short return visit (20+ min) | 141 | $13,619 | $78 |
| New patient visit (45+ min) | 95 | $13,249 | $139 |
| New patient visit (30+ min) | 81 | $8,052 | $99 |
| Diagnostic exam of nasal passages using an endoscope | 39 | $7,751 | $194 |
| Removal of impacted ear wax | 104 | $5,400 | $40 |
| Exam of the nose and throat using an endoscope | 22 | $2,737 | $124 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 12 | $1,627 | $125 |
Who their Medicare patients are
400 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 16% · Women 56% · Also on Medicaid 11% · Health risk score 0.94. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 64% · Diabetes 25% · Coronary heart disease 21% · Chronic kidney disease 20% · Cancer 14% · Atrial fibrillation 13% · Depression 13% · Heart failure 8% · COPD 8% · Stroke 7% · Dementia 6%.
The office billed $413,746, Medicare allowed $137,352 and paid $102,056; for 923 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 400 | 923 | 76 | 0.94 | $413,746 | $102,056 |
| 2023 | 382 | 876 | 76 | 0.87 | $369,310 | $96,943 |
| 2022 | 407 | 1,010 | 77 | 0.93 | $409,823 | $112,522 |
| 2021 | 351 | 825 | 76 | 1.02 | $344,769 | $95,066 |
| 2020 | 291 | 679 | 77 | 1.08 | $262,333 | $67,919 |
| 2019 | 427 | 945 | 76 | 1.13 | $349,582 | $89,240 |
| 2018 | 418 | 930 | 76 | 1.08 | $330,659 | $81,432 |
| 2017 | 364 | 844 | 76 | 1.09 | $313,023 | $74,764 |
| 2016 | 355 | 932 | 75 | 1.08 | $332,706 | $84,062 |
| 2015 | 327 | 788 | 76 | 1.15 | $268,303 | $75,238 |
| 2014 | 353 | 889 | 75 | 1.09 | $288,541 | $75,341 |
| 2013 | 274 | 763 | 75 | 0.97 | $234,260 | $64,734 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 128 | $19,627 | $115 |
| New patient visit (45+ min) | 91 | $13,525 | $149 |
| Diagnostic exam of voice box using a flexible endoscope | 85 | $11,794 | $130 |
| Short return visit (20+ min) | 115 | $11,088 | $78 |
| New patient visit (30+ min) | 85 | $8,285 | $97 |
| Diagnostic exam of nasal passages using an endoscope | 35 | $7,191 | $189 |
| Removal of impacted ear wax | 112 | $5,923 | $42 |
| Exam of the nose and throat using an endoscope | 16 | $1,998 | $125 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 14 | $1,946 | $130 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 11 | $514 | $47 |
2022: 9 services
| Diagnostic exam of voice box using a flexible endoscope | 107 | $17,079 | $131 |
| Return visit (30+ min) | 115 | $16,873 | $115 |
| Short return visit (20+ min) | 149 | $16,407 | $79 |
| New patient visit (45+ min) | 95 | $13,315 | $140 |
| New patient visit (30+ min) | 94 | $9,120 | $97 |
| Diagnostic exam of nasal passages using an endoscope | 36 | $7,141 | $188 |
| Removal of impacted ear wax | 114 | $5,541 | $40 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 20 | $3,115 | $135 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 15 | $801 | $50 |
2021: 8 services
| Short return visit (20+ min) | 127 | $15,296 | $83 |
| Return visit (30+ min) | 95 | $13,666 | $116 |
| Diagnostic exam of voice box using a flexible endoscope | 73 | $12,034 | $129 |
| New patient visit (45+ min) | 60 | $8,749 | $146 |
| New patient visit (30+ min) | 88 | $8,253 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 28 | $5,890 | $203 |
| Removal of impacted ear wax | 91 | $4,263 | $40 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 22 | $3,055 | $127 |
2020: 8 services
| Short return visit (20+ min) | 135 | $13,677 | $66 |
| New patient visit (30+ min) | 99 | $9,115 | $92 |
| Diagnostic exam of voice box using a flexible endoscope | 59 | $8,092 | $121 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $5,974 | $206 |
| Return visit (30+ min) | 48 | $5,200 | $100 |
| Removal of impacted ear wax | 70 | $3,168 | $40 |
| New patient visit (45+ min) | 21 | $2,985 | $142 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 17 | $2,359 | $131 |
2019: 9 services
| Short return visit (20+ min) | 178 | $18,993 | $66 |
| New patient visit (30+ min) | 165 | $15,040 | $91 |
| Diagnostic exam of voice box using a flexible endoscope | 82 | $12,262 | $116 |
| Diagnostic exam of nasal passages using an endoscope | 40 | $10,166 | $203 |
| Return visit (30+ min) | 62 | $5,921 | $94 |
| Removal of impacted ear wax | 98 | $4,460 | $41 |
| New patient visit (45+ min) | 17 | $2,297 | $135 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 14 | $1,865 | $124 |
| Exam of the nose and throat using an endoscope | 13 | $1,401 | $108 |
2018: 12 services
| Short return visit (20+ min) | 169 | $15,656 | $62 |
| New patient visit (30+ min) | 164 | $15,182 | $93 |
| Diagnostic exam of voice box using a flexible endoscope | 91 | $12,231 | $109 |
| Diagnostic exam of nasal passages using an endoscope | 24 | $5,306 | $204 |
| Return visit (30+ min) | 55 | $5,033 | $88 |
| New patient visit (45+ min) | 34 | $4,749 | $140 |
| Removal of impacted ear wax | 94 | $4,619 | $41 |
| Fine needle aspiration using imaging guidance | 15 | $2,149 | $134 |
| Exam of the nose and throat using an endoscope | 13 | $1,685 | $112 |
| Ultrasonic guidance for needle placement | 15 | $823 | $55 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 15 | $766 | $48 |
| Repositioning exercises of head for treatment of dizziness, each day | 14 | $643 | $38 |
2017: 11 services
| New patient visit (30+ min) | 142 | $13,098 | $92 |
| Short return visit (20+ min) | 134 | $12,749 | $62 |
| Diagnostic exam of voice box using a flexible endoscope | 68 | $9,243 | $109 |
| Fine needle aspiration using imaging guidance | 33 | $6,603 | $138 |
| Diagnostic exam of nasal passages using an endoscope | 22 | $5,246 | $210 |
| Removal of impacted ear wax | 94 | $4,370 | $39 |
| Return visit (30+ min) | 48 | $4,271 | $87 |
| Ultrasonic guidance for needle placement | 33 | $2,170 | $57 |
| New patient visit (45+ min) | 14 | $2,128 | $152 |
| Long return visit (40+ min) | 12 | $1,489 | $124 |
| Exam of ear using a microscope | 12 | $394 | $26 |
2016: 14 services
| Short return visit (20+ min) | 153 | $14,965 | $59 |
| New patient visit (30+ min) | 152 | $13,563 | $89 |
| Diagnostic exam of voice box using a flexible endoscope | 77 | $10,751 | $108 |
| Diagnostic exam of nasal passages using an endoscope | 23 | $5,987 | $214 |
| Return visit (30+ min) | 37 | $4,452 | $95 |
| Removal of impacted ear wax | 79 | $3,932 | $39 |
| New patient visit (45+ min) | 21 | $3,193 | $152 |
| Fine needle aspiration using imaging guidance | 15 | $3,049 | $139 |
| Long return visit (40+ min) | 13 | $2,019 | $135 |
| Simple control of nose bleed | 12 | $1,072 | $82 |
| Ultrasonic guidance for needle placement | 15 | $1,059 | $59 |
| Exam of ear using a microscope | 19 | $856 | $29 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $585 | $45 |
| Short return visit | 14 | $555 | $37 |
2015: 10 services
| Short return visit (20+ min) | 160 | $16,245 | $66 |
| New patient visit (30+ min) | 111 | $10,966 | $99 |
| Diagnostic exam of voice box using a flexible endoscope | 75 | $10,606 | $115 |
| Diagnostic exam of nasal passages using an endoscope | 24 | $7,533 | $222 |
| Return visit (30+ min) | 52 | $5,471 | $101 |
| Removal of impacted ear wax | 84 | $4,071 | $40 |
| Fine needle aspiration using imaging guidance | 15 | $3,816 | $141 |
| Exam of the nose and throat using an endoscope | 11 | $1,620 | $147 |
| Ultrasonic guidance for needle placement | 13 | $825 | $59 |
| Short return visit | 16 | $731 | $41 |
2014: 9 services
| Short return visit (20+ min) | 159 | $16,709 | $62 |
| New patient visit (30+ min) | 126 | $10,903 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 76 | $9,076 | $111 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $6,490 | $209 |
| Return visit (30+ min) | 58 | $5,164 | $85 |
| Removal of impacted ear wax | 99 | $4,657 | $38 |
| Fine needle aspiration using imaging guidance | 23 | $3,946 | $136 |
| Ultrasonic guidance for needle placement | 22 | $1,798 | $72 |
| Short return visit | 28 | $1,364 | $37 |
2013: 9 services
| Short return visit (20+ min) | 127 | $13,348 | $62 |
| Diagnostic exam of voice box using a flexible endoscope | 53 | $9,010 | $110 |
| New patient visit (30+ min) | 85 | $7,739 | $91 |
| Diagnostic exam of nasal passages using an endoscope | 25 | $6,571 | $212 |
| Removal of impacted ear wax | 86 | $4,626 | $41 |
| Return visit (30+ min) | 32 | $4,048 | $99 |
| New patient visit (45+ min) | 14 | $2,071 | $148 |
| Short return visit | 38 | $1,554 | $38 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $287 | $16 |
Drugs they prescribed that Part D paid
$6,108
Pharmacies billed $6,108 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
205 generic and 12 brand-name prescriptions · $6,108 in drug cost · 34 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azelastine | 33 | $1,281 | $39 |
| Ipratropium | 26 | $693 | $27 |
| Fluocinolone Acetonide Oil | 14 | $397 | $28 |
| Fluticasone Propionate | 12 | $200 | $17 |
| Prednisone | 26 | $155 | $6 |
See all 6 drugs
| Azelastine | 33 | $1,281 | $39 |
| Ipratropium | 26 | $693 | $27 |
| Fluocinolone Acetonide Oil | 14 | $397 | $28 |
| Fluticasone Propionate | 12 | $200 | $17 |
| Prednisone | 26 | $155 | $6 |
| Amoxicillin-Clavulanate Potass | 18 | $123 | $7 |
Year by year
| 2024 | 217 | 109 | None | 6% | $6,108 |
| 2023 | 199 | 95 | None | None | $7,262 |
| 2022 | 225 | 94 | None | 5% | $9,011 |
| 2021 | 185 | 92 | None | 6% | $7,874 |
| 2020 | 167 | 79 | None | 13% | $9,474 |
| 2019 | 211 | 98 | None | 9% | $7,639 |
| 2018 | 152 | 80 | None | None | $4,227 |
| 2017 | 155 | 78 | None | 8% | $4,561 |
| 2016 | 227 | 108 | None | 9% | $8,224 |
| 2015 | 235 | 103 | None | 6% | $7,178 |
| 2014 | 332 | 113 | None | 9% | $13,442 |
| 2013 | 300 | 114 | None | 8% | $10,974 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Azelastine | 52 | $1,910 | $37 |
| Ipratropium | 32 | $1,651 | $52 |
| Ofloxacin | 16 | $795 | $50 |
2022: 6 drugs
| Azelastine | 41 | $1,704 | $42 |
| Ofloxacin | 13 | $1,199 | $92 |
| Ipratropium | 16 | $828 | $52 |
| Fluticasone Propionate | 12 | $294 | $25 |
| Amoxicillin-Clavulanate Potass | 13 | $191 | $15 |
| Prednisone | 20 | $190 | $9 |
2021: 4 drugs
| Ofloxacin | 24 | $1,181 | $49 |
| Azelastine | 29 | $1,023 | $35 |
| Fluticasone Propionate | 17 | $517 | $30 |
| Cephalexin | 12 | $110 | $9 |
2020: 5 drugs
| Mometasone Furoate | 18 | $2,122 | $118 |
| Ofloxacin | 17 | $1,430 | $84 |
| Azelastine | 30 | $1,156 | $39 |
| Ipratropium | 12 | $601 | $50 |
| Fluticasone Propionate | 14 | $476 | $34 |
2019: 8 drugs
| Fluocinolone Acetonide Oil | 11 | $1,290 | $117 |
| Ofloxacin | 18 | $1,236 | $69 |
| Azelastine | 29 | $913 | $31 |
| Fluticasone Propionate | 13 | $319 | $25 |
| Acetic Acid | 11 | $251 | $23 |
| Amoxicillin-Clavulanate Potass | 15 | $249 | $17 |
| Nystatin | 11 | $172 | $16 |
| Prednisone | 18 | $142 | $8 |
2018: 5 drugs
| Fluticasone Propionate | 25 | $636 | $25 |
| Azelastine | 21 | $607 | $29 |
| Ipratropium | 12 | $453 | $38 |
| Amoxicillin-Clavulanate Potass | 15 | $255 | $17 |
| Prednisone | 12 | $127 | $11 |
2017: 4 drugs
| Fluticasone Propionate | 32 | $860 | $27 |
| Ipratropium | 21 | $768 | $37 |
| Azelastine | 11 | $343 | $31 |
| Ciprofloxacin | 12 | $216 | $18 |
2016: 9 drugs
| Fluocinolone Acetonide Oil | 12 | $1,630 | $136 |
| Fluticasone Propionate | 41 | $973 | $24 |
| Azelastine | 12 | $868 | $72 |
| Ipratropium | 17 | $348 | $20 |
| Acetic Acid | 16 | $319 | $20 |
| Amoxicillin-Clavulanate Potass | 19 | $311 | $16 |
| Ciprofloxacin | 11 | $166 | $15 |
| Prednisone | 15 | $114 | $8 |
| Cephalexin | 11 | $98 | $9 |
2015: 6 drugs
| Fluticasone Propionate | 63 | $963 | $15 |
| Azelastine | 19 | $839 | $44 |
| Ofloxacin | 11 | $577 | $52 |
| Omeprazole | 18 | $274 | $15 |
| Amoxicillin-Clavulanate Potass | 16 | $241 | $15 |
| Prednisone | 18 | $165 | $9 |
2014: 4 drugs
| Azelastine | 62 | $3,295 | $53 |
| Fluticasone Propionate | 108 | $1,904 | $18 |
| Omeprazole | 25 | $483 | $19 |
| Ofloxacin | 11 | $422 | $38 |
2013: 8 drugs
| Fluticasone Propionate | 94 | $2,301 | $24 |
| Azelastine | 22 | $1,426 | $65 |
| Omeprazole | 37 | $845 | $23 |
| Ofloxacin | 15 | $396 | $26 |
| Amox Tr-Potassium Clavulanate | 13 | $332 | $26 |
| Ipratropium | 12 | $243 | $20 |
| Triamterene-Hctz | 12 | $120 | $10 |
| Prednisone | 13 | $77 | $6 |
Money from drug and device companies
$19 in 2024
A payment is not proof that care is biased.
| Smith+Nephew | Halo | $19 | 1 payment
|
See the published payment
| Smith+Nephew | Meals · 2024-09-24 | Halo | $19 |
Professional record
- NPI
- 1710015557
- Licence
- CA A95926California A95926: Current · expires 2028-01-31
- Trained
- University of California, Davis School of Medicine, 2004
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-03-01
- NPI last updated
- 2011-12-07
This is when the NPI record was last certified, not a medical board exam.